Follow us:
Celther Poland offers a two-day training on methods for obtaining, identifying, cultivating and differentiating iPS.
Celther Polska has been awarded “WPROST Innovator” 2016 title in the Pharmacy category.
January 06, 2018 the newest article based on Celther research was published online on Oncotarget.
Primary cells isolated directly from tissue provide conditions that closely simulate a living model.
Start your iPS cell research with custom-made, high quality iPS cell lines.
Use adult human body cells provided by Celther to test safety of your drug candidates.
Use iNSc to drug discovery and weed out ineffective and potentially neurotoxic compounds.
Human iPS cells with 18 chromosome trisomy - High viability - Easy to culture
Take advantage of a complete "Drug discovery and development" service provided by Celther.
Genetic Engineering - Molecular and Cell Biology - Cell cultures and iPS cell cultures.
Synthesis, formulation, physicochemical and biocompability analysis of polymers.
In vitro toxicity testing services
Celther provides highly specialized in vitro examination of potential drug candidate compounds, using a plethora of methods, including real time cell observation.
Celther Induced Cardiomyocytes
Celther presents spontaneously beating human iPSderived cardiomyocytes, an excellent tool for cardiotoxicity testing and discovery of novel cardiac drug targets.